Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM‐D registry

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 434-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005–2013

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 4, 2015-04 ,pp. : 225-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison

By  

MYCOSES (ELECTRONIC), Vol. 61, Iss. 3, 2018-03 ,pp. : 206-212

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective assessment of secondary prophylaxis for invasive aspergillosis in neutropenic hematology patients and identification of risk factors for relapse of fungal disease

By Kikuchi Misato  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 7, 2013-07 ,pp. : 531-536

Informa Healthcare

Access to resources Recommend Favorite

The value of CMV and fungal PCR for monitoring of acute leukaemia and autologous stem cell transplant patients

By Ljungman Per   Von Döbeln Lovisa   Ringholm Lotta   Lewensohn-Fuchs Ilona   Klingspor Lena   Sparrelid Elda  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 2, 2005-02 ,pp. : 121-126

Informa Healthcare

Access to resources Recommend Favorite